COVID-19 Miniseries Episode 14: An Overview of Pulmonary Critical Care for COVID-19 Patients
This episode was recorded on April 15, 2020.
To claim credit visit: https://ce.mayo.edu/covid19podcast
When a patient presents with dyspnea how can we reliably predict who will progress to respiratory failure? How can phenotypes of disease progression be utilized for optimizing selection of treatment modalities? Dr. Alex Niven discusses Fleischner Society recommendations for imaging as a COVID-19 screening tool, cytokine storm, ventilator-associated lung injury, post-ICU care syndrome, and humanity in critical care.
- Mayo Clinic COVID-19 Resources for Providers https://www.mayoclinic.org/medical-professionals/provider-relations/covid-19-resources-for-providers
- Fleischner Society GuidelinesRubin G, Haramati L, Kanne J, et al. The role of chest imaging in patient management during the COVID-19 pandemic: A multinational consensus statement from the Fleischner Society. Radiology. 2020 April 07; p.201365. https://doi.org/10.1148/radiol.2020201365
- The Berlin DefinitionThe ARDS Definition Task Force. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23):2526–2533. doi:10.1001/jama.2012.5669